These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 22580601)
1. Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion. Muller PA; Trinidad AG; Timpson P; Morton JP; Zanivan S; van den Berghe PV; Nixon C; Karim SA; Caswell PT; Noll JE; Coffill CR; Lane DP; Sansom OJ; Neilsen PM; Norman JC; Vousden KH Oncogene; 2013 Mar; 32(10):1252-65. PubMed ID: 22580601 [TBL] [Abstract][Full Text] [Related]
2. Mutant p53 regulates Dicer through p63-dependent and -independent mechanisms to promote an invasive phenotype. Muller PA; Trinidad AG; Caswell PT; Norman JC; Vousden KH J Biol Chem; 2014 Jan; 289(1):122-32. PubMed ID: 24220032 [TBL] [Abstract][Full Text] [Related]
3. Functions of TAp63 and p53 in restraining the development of metastatic cancer. Tan EH; Morton JP; Timpson P; Tucci P; Melino G; Flores ER; Sansom OJ; Vousden KH; Muller PA Oncogene; 2014 Jun; 33(25):3325-33. PubMed ID: 23873029 [TBL] [Abstract][Full Text] [Related]
4. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors. Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation. Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180 [TBL] [Abstract][Full Text] [Related]
6. Mutant p53 drives invasion by promoting integrin recycling. Muller PA; Caswell PT; Doyle B; Iwanicki MP; Tan EH; Karim S; Lukashchuk N; Gillespie DA; Ludwig RL; Gosselin P; Cromer A; Brugge JS; Sansom OJ; Norman JC; Vousden KH Cell; 2009 Dec; 139(7):1327-41. PubMed ID: 20064378 [TBL] [Abstract][Full Text] [Related]
8. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Wang SP; Wang WL; Chang YL; Wu CT; Chao YC; Kao SH; Yuan A; Lin CW; Yang SC; Chan WK; Li KC; Hong TM; Yang PC Nat Cell Biol; 2009 Jun; 11(6):694-704. PubMed ID: 19448627 [TBL] [Abstract][Full Text] [Related]
9. EGF receptor activates MET through MAPK to enhance non-small cell lung carcinoma invasion and brain metastasis. Breindel JL; Haskins JW; Cowell EP; Zhao M; Nguyen DX; Stern DF Cancer Res; 2013 Aug; 73(16):5053-65. PubMed ID: 23794705 [TBL] [Abstract][Full Text] [Related]
10. Mutant p53 promotes RCP-dependent chemoresistance coinciding with increased delivery of P-glycoprotein to the plasma membrane. Phatak V; von Grabowiecki Y; Janus J; Officer L; Behan C; Aschauer L; Pinon L; Mackay H; Zanivan S; Norman JC; Kelly M; Le Quesne J; Muller PAJ Cell Death Dis; 2021 Feb; 12(2):207. PubMed ID: 33627632 [TBL] [Abstract][Full Text] [Related]
11. Novel Role for γ-Catenin in the Regulation of Cancer Cell Migration via the Induction of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1). Sechler M; Borowicz S; Van Scoyk M; Avasarala S; Zerayesus S; Edwards MG; Kumar Karuppusamy Rathinam M; Zhao X; Wu PY; Tang K; Bikkavilli RK; Winn RA J Biol Chem; 2015 Jun; 290(25):15610-15620. PubMed ID: 25925948 [TBL] [Abstract][Full Text] [Related]
12. Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer. Ali A; Bhatti MZ; Shah AS; Duong HQ; Alkreathy HM; Mohammad SF; Khan RA; Ahmad A J Biol Chem; 2015 Aug; 290(35):21336-51. PubMed ID: 25911104 [TBL] [Abstract][Full Text] [Related]
13. MET-dependent cancer invasion may be preprogrammed by early alterations of p53-regulated feedforward loop and triggered by stromal cell-derived HGF. Hwang CI; Choi J; Zhou Z; Flesken-Nikitin A; Tarakhovsky A; Nikitin AY Cell Cycle; 2011 Nov; 10(22):3834-40. PubMed ID: 22071625 [TBL] [Abstract][Full Text] [Related]
14. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Hwang CI; Matoso A; Corney DC; Flesken-Nikitin A; Körner S; Wang W; Boccaccio C; Thorgeirsson SS; Comoglio PM; Hermeking H; Nikitin AY Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14240-5. PubMed ID: 21831840 [TBL] [Abstract][Full Text] [Related]
15. ETS2 mediated tumor suppressive function and MET oncogene inhibition in human non-small cell lung cancer. Kabbout M; Garcia MM; Fujimoto J; Liu DD; Woods D; Chow CW; Mendoza G; Momin AA; James BP; Solis L; Behrens C; Lee JJ; Wistuba II; Kadara H Clin Cancer Res; 2013 Jul; 19(13):3383-95. PubMed ID: 23659968 [TBL] [Abstract][Full Text] [Related]
16. A common p53 mutation (R175H) activates c-Met receptor tyrosine kinase to enhance tumor cell invasion. Grugan KD; Vega ME; Wong GS; Diehl JA; Bass AJ; Wong KK; Nakagawa H; Rustgi AK Cancer Biol Ther; 2013 Sep; 14(9):853-9. PubMed ID: 23792586 [TBL] [Abstract][Full Text] [Related]
17. AXL and MET receptor tyrosine kinases are essential for lung cancer metastasis. Choi YJ; Kim JH; Rho JK; Kim JS; Choi CM; Kim WS; Son J; Lee JC Oncol Rep; 2017 Apr; 37(4):2201-2208. PubMed ID: 28260071 [TBL] [Abstract][Full Text] [Related]
18. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397 [TBL] [Abstract][Full Text] [Related]
19. Non-canonical p53 signaling to promote invasion. Dent P Cancer Biol Ther; 2013 Oct; 14(10):879-80. PubMed ID: 24025254 [TBL] [Abstract][Full Text] [Related]
20. Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53. Liu WT; Jing YY; Yu GF; Chen H; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX Cell Cycle; 2016; 15(7):886-94. PubMed ID: 27077227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]